SCHEMBL7309436

SCHEMBL7309436

COc1ccc(S(=O)(=O)C(CC2CCCC2)C(C(=O)NOC(C)(C)C)C(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 10/20 0.50
MMP3 P08254 8/20 0.50
MMP2 P08253 7/20 0.50
MMP13 P45452 7/20 0.45
MMP9 P14780 3/20 0.45
ADAM17 P78536 1/20 0.45
MMP8 P22894 2/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 2/20 0.40
KLK7 P49862 1/20 0.40
MMP7 P09237 1/20 0.39
USP2 O75604 1/20 0.39
HTT P42858 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7302606 0.88 MMP1 (0.56) MMP1MMP3MMP2MMP13MMP9
SCHEMBL7308312 0.79 ALDH1A1 (0.41) MMP1MMP3MMP13MMP9ADAM17
SCHEMBL7311450 0.78 MMP3 (0.63) MMP1MMP3MMP2MMP13MMP9
SCHEMBL7301899 0.75 MMP1 (0.49) MMP1MMP3MMP2MMP13MMP9
SCHEMBL7305749 0.74 MMP13 (0.71) MMP1MMP3MMP2MMP13MMP9
SCHEMBL7309053 0.69 MMP3 (0.78) MMP1MMP3MMP2MMP13MMP9
SCHEMBL6931861 0.68 MMP1 (0.52) MMP1MMP3MMP2MMP13MMP9
SCHEMBL7310255 0.67 EPHX2 (0.43) MMP1MMP3MMP2MMP13MMP9
SCHEMBL27461841 0.66 ALDH1A1 (0.42) MMP1MMP3MMP2MMP13MMP9
SCHEMBL7298812 0.66 MMP1 (0.42) MMP1MMP3MMP2MMP13MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed